Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in Cape Town, South Africa
Article Sidebar
Main Article Content
Abstract
Background. Pulmonary endarterectomy (PEA) is the only definitive and potentially curative therapy for chronic thromboembolic
pulmonary hypertension (CTEPH), associated with impressive improvements in symptoms and haemodynamics. However, it is only
offered at a few centres in South Africa. The characteristics and outcomes of patients undergoing PEA in Cape Town have not been
reported previously.
Objectives. To assess the difference in World Health Organization functional class (WHO-FC) before and at least 6 weeks after surgery.
Methods. We interrogated the adult cardiothoracic surgery database at the University of Cape Town between December 2005 and April 2021 for patients undergoing PEA at Groote Schuur Hospital and a private hospital.
Results. A total of 32 patients underwent PEA, of whom 8 were excluded from the final analysis owing to incomplete data or a histological diagnosis other than CTEPH. The work-up of these patients for surgery was variable: all had a computed tomography pulmonary angiogram, 7 (29%) had a ventilation/perfusion scan, 5 (21%) underwent right heart catheterisation, and none had a pulmonary angiogram. The perioperative mortality was 4/24 (17%): 1 patient (4%) had a cardiac arrest on induction of anaesthesia, 2 patients (8%) died of postoperative pulmonary haemorrhage, and 1 patient (4%) died of septic complications in the intensive care unit. Among the survivors, the median (interquartile range) improvement in WHO-FC was 2 (1 - 3) classes (p=0.0004); 10/16 patients (63%) returned to a normal baseline (WHO-FC I).
Conclusion. Even in a low-volume centre, PEA is associated with significant improvements in WHO-FC and a return to a normal baseline in survivors.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37(1):67-119. https://doi. org/10.1093/eurheartj/ehv317
Wilkens H, Konstantinides S, Lang IM, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol 2018;272S:69-78. https://doi.org/10.1016/j. ijcard.2018.08.079
Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): Results from an international prospective registry. Circulation 2011;124(18):1973-1981. https://doi.org/10.1161/circulationaha.110.015008
De Perrot M, Gopalan D, Jenkins D, et al. Evaluation and management of patients with chronic thromboembolic pulmonary hypertension – consensus statement from the ISHLT. J Heart Lung Transplant 2021;40(11):1301-1326. https://doi.org/10.1016/j. healun.2021.07.020
Delcroix M, Kerr K, Fedullo P. Chronic thromboembolic pulmonary hypertension: Epidemiology and risk factors. Ann Am Thorac Soc 2016;13(Suppl 3):S201-S206. https://doi.org/10.1513/AnnalsATS.201509-621AS
KimNH,LangIM.Riskfactorsforchronicthromboembolicpulmonaryhypertension. Eur Respir Rev 2012;21(123):27-31. https://doi.org/10.1183/09059180.00009111
Lang IM, Dorfmüller P, Vonk Noordegraaf A. The pathobiology of chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc 2016;13(Suppl 3):S215-S221. https://doi.org/10.1513/AnnalsATS.201509-620AS
Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2022;43(38):3618-731. https:// doi.org/10.55788/c838601b
Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: Experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003;76(5):1457- 1462. https://doi.org/10.1016/s0003-4975(03)00828-2
Madani MM, Auger WR, Pretorius V, et al. Pulmonary endarterectomy: Recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg 2012;94(1):97-103. https://doi.org/10.1016/j.athoracsur.2012.04.004
Condliffe R, Kiely DG, Gibbs JS, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2008;177(10):1122-1127. https://doi.org/10.1164/rccm.200712- 1841OC
Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry. J Thorac Cardiovasc Surg 2011;141(3):702-710. https://doi.org/10.1016/j.jtcvs.2010.11.024
Thistlethwaite PA, Kaneko K, Madani MM, Jamieson SW. Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg 2008;14(5):274- 282.
Matsuda H, Ogino H, Minatoya K, et al. Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 2006;82(4):1338-1343. https://doi.org/10.1016/j. athoracsur.2006.03.105
Skoro-Sajer N, Marta G, Gerges C, et al. Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy. Thorax 2014;69(2):116-122. https://doi.org/10.1136/thoraxjnl-2013-203746
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 2007;370(9596):1453-1457. https://doi.org/10.1016/s0140-6736(07)61602-x
Valerio L, Mavromanoli AC, Barco S, et al. Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: The FOCUS study. Eur Heart J 2022;43(36):3387-3398. https://doi.org/10.1093/eurheartj/ehac206
Bulajic B, Welzel T, Vallabh K. Clinical presentation and diagnostic work up of suspected pulmonary embolism in a district hospital emergency centre serving a high HIV/TB burden population. Afr J Emerg Med 2019;9(3):134-139. https://doi. org/10.1016/j.afjem.2019.05.003
Ramlakhan R, Andronikou S, Rajkumar A. The prevalence and radiological findings of pulmonary embolism in HIV-positive patients referred for computed tomography pulmonary angiography in the Western Cape of South Africa. Cardiovasc J Afr 2017;28(4):221-228. https://doi.org/10.5830/cvja-2016-083
Davies-van Es S, Calligaro G, Manning K, Williams H, Dheda K, Symons G. The aetiology, clinical presentation and treatment of patients with pulmonary hypertension in Cape Town: A preliminary report from the Groote Schuur Hospital Pulmonary Hypertension Registry. Afr J Thorac Crit Care Med 2018;24(4):133-138. https://doi.org/10.7196/ajtccm.2018.v24i4.218
Madani MM. Surgical treatment of chronic thromboembolic pulmonary hypertension: Pulmonary thromboendarterectomy. Methodist DeBakey Cardiovasc J 2016;12(4):213-218. https://doi.org/10.14797/mdcj-12-4-213
Shudo Y, Wang H, Lingala B, et al. Evaluation of risk factors for heart-lung transplant recipient outcome: An analysis of the United Network for Organ Sharing Database. Circulation 2019;140(15):1261-1272. https://doi.org/10.1161/ circulationaha.119.040682
Thourani VH, Brennan JM, Edelman JJ, et al. Association of volume and outcomes in 234 556 patients undergoing surgical aortic valve replacement. Ann Thorac Surg 2022;114(4):1299-1306. https://doi.org/10.1016/j.athoracsur.2021.06.095
Russo MJ, Iribarne A, Easterwood R, et al. Post-heart transplant survival is inferior at low-volume centers across all risk strata. Circulation 2010;122(11 Suppl):S85-S91. https://doi.org/10.1161/circulationaha.109.926659
Tie HT, Shi R, Zhou Q, Wang K, Zheng XQ, Wu QC. Annual case volume on mortality after coronary artery bypass grafting: A dose-response meta-analysis. Interact Cardiovasc Thorac Surg 2019;29(4):568-575. https://doi.org/10.1093/icvts/ ivz151
Cervilla-Munoz E, Galeano-Valle F, Del-Toro-Cervera J, Calleja-Carton E, Demelo- Rodriguez P. Differential diagnosis and treatment approach to pulmonary artery sarcoma: A case report and literature review. ERJ Open Res 2020;6(3):00124-2020. https://doi.org/10.1183/23120541.00124-2020
D’Armini AM, Morsolini M, Mattiucci G, et al. Pulmonary endarterectomy for distal chronic thromboembolic pulmonary hypertension. J Thorac Cardiovascular Surg 2014;148(3):1005-1011. https://doi.org/10.1016/j.jtcvs.2014.06.05224
Jenkins DP, Biederman A, D’Armini AM, et al. Operability assessment in CTEPH: Lessons from the CHEST-1 study. J Thoracic Cardiovasc Surg 2016;152(3):669-674. e3. https://doi.org/10.1016/j.jtcvs.2016.02.062